
Northwest BioTherapeutics, Inc (NASDAQ:NWBO) Reports Positive Result In DCVax-Direct Phase I/II Study
Boston, MA 06/11/2014 (wallstreetpr) – Northwest BioTherapeutics, Inc (NASDAQ:NWBO) reported significantly positive results in its Phase I/II clinical trial involving DCVax-Direct to treat various kinds













